x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > ONLINE EVENT: 5th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers
Print

Description

Due to the current situation with COVID-19 we have decided that the event will be held online.
Please, find out the latest information about this online course on www.e-ESO.net.

Chairs:
J.Y. Blay, FR - P.G. Casali, IT - R. Stahel, CH

INTRODUCTION
The “ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers” is an educational effort held on an annual basis and conceived to strengthen the education of medical professionals willing to devote their career to rare cancers.

Despite being rare as single entities, rare adult solid cancers account for as many as 15% of all new cancer cases, thus being the main group within rare cancers in general. The definition of rare cancers by the RARECARE project and the list of the 10 “families” of rare adult solid cancers it gave rise to shape the sessions of this course:

• Head & neck cancers
• Sarcomas
• Rare thoracic tumors
• Neuroendocrine tumors
• Central nervous system neoplasms
• Rare female genital cancers
• Endocrine gland tumors
• Digestive rare cancers
• Rare urological and male genital tumors
• Rare skin cancers & non-cutaneous melanoma

Since ‘networking’ and ‘multidisciplinarity’ are the two main keywords to improve the quality of care of rare cancers, ESO has decided to develop the programme of this course in collaboration with other European initiatives in this field and to give its contribution to tackle the rare cancer issue. The “5th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers” is conceived in the context of, and supported by, EURACAN, the European Reference Network on rare adult solid cancers. The Faculty has been largely selected from EURACAN, also with the aim of letting this educational effort closely interact with its networking activities.

Optimal management of rare adult solid cancers poses specific diagnostic and therapeutic challenges. The sessions of the course have been designed to address the needs of clinical oncologists wanting an update on recent advancements on these tumours.

The global health crisis caused by the Covid-19 pandemic has forced us to turn the in-person 5th Advanced Course ESO-ESMO-RCE CLINICAL UPDATE on RARE ADULT SOLID CANCERS into a virtual event. It will be a good opportunity to receive updates on the available evidence in this field and promote future networking and collaborations.

We have done our best to design an online course enabling participants to attend according to their own schedule. There will be a mixture of Pre-recorded sessions and Live sessions for Q & A and clinical case discussions with faculty members and moderators.

INFORMATION ON THE COURSE STRUCTURE
The course will be carried out in two different steps.

Step 1:
Pre-recorded sessions will be made available from 1st December 2020 and will remain on the e-eso website. You will be able to see all the sessions in your own time and send questions that will be selected for discussion during Step 2 of the course. Please remember that registration to the full course is free but mandatory in order to gain access to the sessions.

Step 2:
Live sessions with an introductory round table on rare cancers in general, clinical case presentations and Q&A discussions with moderators and speakers will be held on 16 and 17 January 2021 (please see the detailed programme). During the Q&A sessions, speakers will answer and discuss a number of selected questions received in advance via email (see below for instructions) and/or during the live streaming via chat.

Q&A sessions:
Participants are encouraged to send questions in advance, as long as they listen to the recorded sessions. The moderators will select questions to be answered during the live streaming. Questions should be sent to raretumours@eso.net, no later than 4 January 2021. Please indicate the session title and speaker your question refers to.

LEARNING OBJECTIVES
Provide an update on the latest developments in the area of rare adult solid cancers, with a background perspective on state-of-the-art and evidence based practice.

The course is an ESO-ESMO-RCE joint event          
RCE         ESMO
Held in collaboration with          
 INT          
In partnership with          
         

 

Faculty

INVITED FACULTY
Tit Albreht, National Institute of Public Health, ., Ljubljana, SI
Martina Angi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Judith Balmana, Vall d'Hebron Institute of Oncology, Medical Oncology Dept., Barcelona, ES
Alfredo Berruti, ASST Spedali Civili, Brescia, IT
Jean-Yves Blay, Centre Léon Bérard, Lyon, FR
Jaume Capdevila, Vall d'Hebron University Hospital, Barcelona, ES
Martyn Caplin, Royal Free Hospital, London, UK
Paolo Giovanni Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Stefano Cavalieri, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Filippo De Braud, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Loris De Cecco, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Christelle de la Fouchardiere, Centre Léon Bérard, Lyon, FR
Francesco De Lorenzo, ECPC, European Cancer Patient Coalition, Brussels, BE
Marcello Deraco, Fondazione IRCCS Istituto NazionaleTumori, Milan, IT
Nicola Fazio, European Institute of Oncology, Milan, IT
Silvia Franceschi, Centro Riferimento Oncologico, Struttura Complessa Epidemiologia Oncologica, Aviano, IT
Anna Maria Frezza, Fondazione IRCCS Istituto NazionaleTumori, Milan, IT
Marina Garassino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Jourik A. Gietema, University Medical Center, Groningen, NL
Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, London, UK
Vincent Gregoire, Centre Léon Bérard, Lyon, FR
Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Ellen Kapiteijn, University Medical Center, Leiden, NL
Heinz-Josef Klumpen, University of Amsterdam UMC, ., Amsterdam, NL
Ruth Ladenstein, St.Anna-Kinderspital, Children’s Cancer Research Institute, Vienna, AT
Celeste Lebbé, Saint Louis Hospital, Paris, FR
Lisa Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Laura Deborah Locati, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Domenica Lorusso, Policlinico Universitario Gemelli, Unità di Oncologia Ginecologica, Roma, IT
Andrea Necchi, National Cancer Institute - IRCCS Foundation, Medical Oncology Dept., Milan, IT
Monica Niger, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Kathy Oliver, International Brain Tumour Alliance, Tadworth, UK
Fedro Alessandro Peccatori, European Institute of Oncology, Milan, IT
Cesare Piazza, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Sophie Piperno-Neumann, Curie Institute, Paris, FR
Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, FR
Carlo Resteghini, Fondazione IRCCS Istituto Nazionali Tumori, Milan, IT
Michael Seckl, Imperial College Hammersmith Campus, London, UK
Christian Simon, Centre Hospitalier Universitaire Vaudois, Lausanne, CH
Riccardo Soffietti, City of Health and Science University Hospital, Torino, IT
Silvia Stacchiotti, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Rolf A. Stahel, Comprehensive Cancer Center University Hospital, Zurich, CH
Sandra Strauss, UCL Cancer Institute, Medical Oncology Dept., London, GB
Annalisa Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Martin J. Van den Bent, Erasmus M.C. Cancer Center, Rotterdam, NL
Lucjan Wyrwicz, Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, PL

General information

ORGANISING SECRETARIAT
European School of Oncology
Rare Tumours Programme
c/o Fondazione IRCCS Istituto Nazionale dei Tumori
Via G. Venezian, 1
20133 Milano - Italy
Fax +39 0223902531
Email: raretumours@eso.net

OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.


ACCREDITATION
Participants will be issued a certificate of attendance.
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

ESCO CREDITS



The course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the course earns participants 22 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

Registration

IDEAL PARTICIPANT’S PROFILE
• Medical degree
• Specialization/residency in medical oncology, radiation oncology, surgical oncology or equivalent

REGISTRATION

Registration for the event is free but mandatory.

CONFIRMATION OF REGISTRATION
Registration will be confirmed by e-mail.

All the contents will be recorded and accessible via the e-ESO website during and after the event
(registration to access the contents will remain open after the event).

REGISTER ONLINE HERE

Programme

1 December

 THE JOINT ACTION ON RARE CANCERS: WHAT NEXT?
Pre-recorded sessions available from 1 December 2020
Moderators: Jean-Yves Blay, FR - Fedro Alessandro Peccatori, IT
  The rare cancer agenda 2030
Paolo Giovanni Casali, IT
  The epidemiology of rare adult solid cancers
Annalisa Trama, IT
  EURACAN: where we are?
Jean-Yves Blay, FR
  An educational pathway on rare adult solid cancers
Anna Maria Frezza, IT
 UPDATE ON RARE THORACIC CANCERS
Pre-recorded sessions available from 1 December 2020
Moderators: Marina Garassino, IT - Rolf A. Stahel, CH
  Mesothelioma
Rolf A. Stahel, CH
  Thymic tumors
Marina Garassino, IT
 UPDATE ON SARCOMAS
Pre-recorded sessions available from 1 December 2020
Moderators: Jean-Yves Blay, FR - Paolo Giovanni Casali, IT
  Adult soft tissue sarcomas
Paolo Giovanni Casali, IT
  GIST
Jean-Yves Blay, FR
  Ewing sarcoma and osteosarcoma
Sandra Strauss, GB
  Rare bone and soft tissue sarcomas
Silvia Stacchiotti, IT
  Improving the surgical margin in sarcomas
Alessandro Gronchi, IT
 UPDATE ON HEAD AND NECK CANCERS
Pre-recorded sessions available from 1 December 2020
Moderators: Vincent Gregoire, FR - Lisa Licitra, IT
  Laryngeal & hypopharyngeal carcinoma
Cesare Piazza, IT
  Oropharyngeal carcinoma
Vincent Gregoire, FR
  Nasopharyngeal carcinoma & sinonasal cancers
Lisa Licitra, IT
  Salivary gland tumors
Laura Deborah Locati, IT
  Oral cavity tumors
Christian Simon, CH
  Advances in molecular biology
Loris De Cecco, IT
 UPDATE ON NEUROENDOCRINE TUMORS
Pre-recorded sessions available from 1 December 2020
Moderators: Martyn Caplin, GB - Filippo De Braud, IT
  Thoracic NETs
Martyn Caplin, GB
  Gastroenteropancreatic NETs
Nicola Fazio, IT
 UPDATE ON CNS TUMORS
Pre-recorded sessions available from 1 December 2020
Moderators: Riccardo Soffietti, IT - Martin J. Van den Bent, NL
  Gliomas
Riccardo Soffietti, IT
  Rare CNS tumors
Martin J. Van den Bent, NL
  Hereditary cancer risk syndromes
Judith Balmana, ES
 UPDATE ON ENDOCRINE GLAND TUMORS
Pre-recorded sessions available from 1 December 2020
Moderators: Christelle de la Fouchardiere, FR - Lisa Licitra, IT
  Adrenal cancer
Alfredo Berruti, IT
  Thyroid cancer
Jaume Capdevila, ES
  The epidemiological evidence of sovradiagnosis
Silvia Franceschi, IT
 UPDATE ON DIGESTIVE RARE CANCERS
Pre-recorded sessions available from 1 December 2020
Moderators: Filippo De Braud, IT - Lucjan Wyrwicz, PL
  Biliary tumors
Heinz-Josef Klumpen, NL
  Anal carcinoma
Robert Glynne-Jones, GB
  Peritoneal mesothelioma & pseudomyxoma
Marcello Deraco, IT
 UPDATE ON RARE UROGENITAL CANCERS
Pre-recorded sessions available from 1 December 2020
Moderators: Jourik A. Gietema, NL - Andrea Necchi, IT
  Testicular cancer
Jourik A. Gietema, NL
  Penile cancer
Andrea Necchi, IT
  Survivorship as a healthcare issue
Tit Albreht, SI
  Survivorship as a clinical issue
Ruth Ladenstein, AT
 UPDATE ON RARE FEMALE GENITAL CANCERS
Pre-recorded sessions available from 1 December 2020
Moderators: Fedro Alessandro Peccatori, IT - Michael Seckl, GB
  Non-epithelial ovarian tumors
Isabelle Ray-Coquard, FR
  Trophoblastic tumors
Michael Seckl, GB
  Vulvar and vaginal cancers
Domenica Lorusso, IT
 UPDATE ON RARE SKIN TUMORS AND UVEAL MELANOMA
Pre-recorded sessions available from 1 December 2020
Moderators: Ellen Kapiteijn, NL - Sophie Piperno-Neumann, FR
  Merkel cell carcinoma
Celeste Lebbé, FR
  Cutaneous adnexal malignancies
Stefano Cavalieri, IT
  Uveal melanoma
Martina Angi, IT

16 January

11:30LIVE SESSION - THE JOINT ACTION ON RARE CANCER: WHAT NEXT?
Moderators: Fedro Alessandro Peccatori, IT - Rolf A. Stahel, CH
 11:30Introduction
Fedro Alessandro Peccatori, IT - Rolf A. Stahel, CH
 11:40Round table: The Rare Cancer Agenda 2030
Jean-Yves Blay, FR - Paolo Giovanni Casali, IT - Francesco De Lorenzo, IT - Kathy Oliver, GB - Fedro Alessandro Peccatori, IT - Annalisa Trama, IT
 12:10Q&A and General discussion
12:40LIVE SESSION - UPDATE ON RARE THORACIC CANCERS
Moderators: Marina Garassino, IT - Rolf A. Stahel, CH
 12:40Q&A
Marina Garassino, IT - Rolf A. Stahel, CH
 13:00Clinical case discussion
13:30LIVE SESSION - UPDATE ON SARCOMAS
Moderators: Jean-Yves Blay, FR - Paolo Giovanni Casali, IT
 13:30Q&A
Jean-Yves Blay, FR - Paolo Giovanni Casali, IT - Alessandro Gronchi, IT - Silvia Stacchiotti, IT - Sandra Strauss, GB
 13:50Clinical case discussion
Anna Maria Frezza, IT
14:15LIVE SESSION - UPDATE ON HEAD & NECK CANCERS
Moderators: Vincent Gregoire, FR - Lisa Licitra, IT
 14:15Q&A
Loris De Cecco, IT - Vincent Gregoire, FR - Lisa Licitra, IT - Laura Deborah Locati, IT - Cesare Piazza, IT - Christian Simon, CH
 14:35Clinical case discussion
Carlo Resteghini, IT
15:00LIVE SESSION - UPDATE ON NEUROENDOCRINE TUMORS
Moderators: Martyn Caplin, GB - Filippo De Braud, IT
 15:00Q&A
Martyn Caplin, GB - Filippo De Braud, IT - Nicola Fazio, IT
 15:20Clinical case discussion
15:45LIVE SESSION - UPDATE ON CNS TUMORS
Moderators: Riccardo Soffietti, IT - Martin J. Van den Bent, NL
 15:45Q&A
Judith Balmana, ES - Riccardo Soffietti, IT - Martin J. Van den Bent, NL
 16:05Clinical case discussion

17 January

11:30LIVE SESSION - UPDATE ON ENDOCRINE GLAND TUMORS
Moderators: Christelle de la Fouchardiere, FR - Lisa Licitra, IT
 11:30Q&A
Alfredo Berruti, IT - Jaume Capdevila, ES - Christelle de la Fouchardiere, FR - Silvia Franceschi, IT - Lisa Licitra, IT
 11:50Clinical case discussion
12:15LIVE SESSION - UPDATE ON DIGESTIVE RARE CANCERS
Moderators: Filippo De Braud, IT - Lucjan Wyrwicz, PL
 12:15Q&A
Filippo De Braud, IT - Marcello Deraco, IT - Robert Glynne-Jones, GB - Heinz-Josef Klumpen, NL - Lucjan Wyrwicz, PL
 12:35Clinical case discussion
Monica Niger, IT
13:00LIVE SESSION - UPDATE ON RARE UROGENITAL CANCERS
Moderators: Jourik A. Gietema, NL - Andrea Necchi, IT
 13:00Q&A
Tit Albreht, SI - Jourik A. Gietema, NL - Ruth Ladenstein, AT - Andrea Necchi, IT
 13:20Clinical case discussion
13:45LIVE SESSION - UPDATE ON RARE FEMALE GENITAL CANCERS
Moderators: Fedro Alessandro Peccatori, IT - Michael Seckl, GB
 13:45Q&A
Domenica Lorusso, IT - Fedro Alessandro Peccatori, IT - Isabelle Ray-Coquard, FR - Michael Seckl, GB
 14:05Clinical case discussion
14:30LIVE SESSION - UPDATE ON RARE SKIN TUMORS & UVEAL MELANOMA
Moderators: Ellen Kapiteijn, NL - Sophie Piperno-Neumann, FR
 14:30Q&A
Martina Angi, IT - Stefano Cavalieri, IT - Ellen Kapiteijn, NL - Celeste Lebbé, FR - Sophie Piperno-Neumann, FR
 14:50Clinical case discussion
15:05Closing remarks
Paolo Giovanni Casali, IT

Follow us